Skip to main content
Clinical Trials/IRCT20180421039369N2
IRCT20180421039369N2
Recruiting
未知

The study of the efficacy of the Transdiagnostic Treatment of the Unified for the Improvement of Comorbid Psychological Disorders (Depression, Anxiety and Health Anxiety), Fatigue and Quality of Life in Patients with Multiple Sclerosis (Ms)

Kermanshah University of Medical Sciences0 sites45 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kermanshah University of Medical Sciences
Enrollment
45
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Suffering Ms disease with diagnosis of the neurological department
  • Having a score of less than 5 in the (EDSS) Disability Indicator based on a neurologist's assessment to determine the individual's ability to attend a therapeutic session
  • The age range is between 50 to 18 years old
  • Affliction of emotional coexistence disorders including depression, anxiety and health anxiety based on diagnostic interview by psychologist
  • Motivation and satisfaction for participation during treatment and research implementation
  • Failure to receive psychological treatment in the past year
  • Have at least a cycle of educationNot having other chronic diseases such as severe liver disorder
  • The lack of current diagnosis of any mental disorder is consistent in Diagram 1 and 2 based on a psychologist's diagnostic interview, with the exception of emotional disorders including depression, anxiety and health anxiety
  • No obvious risk of suicide now
  • There is no history of drug abuse or dependence at the current time and within one year before the start of treatment

Exclusion Criteria

  • Unwillingness to attend research meetings
  • Not attending at least 50% of the sessions
  • Creating severe physical problems so that it can not be present at meetings

Outcomes

Primary Outcomes

Not specified

Similar Trials